Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autoantibodies to the 27 C-terminal amino acids of calpastatin are detected in a restricted set of connective tissue diseases and may be useful for diagnosis of rheumatoid arthritis in community cases of very early arthritis.
Vittecoq O, Salle V, Jouen-Beades F, Krzanowska K, Ménard JF, Gayet A, Fardellone P, Tauveron P, Le Loët X, Tron F. Vittecoq O, et al. Rheumatology (Oxford). 2001 Oct;40(10):1126-34. doi: 10.1093/rheumatology/40.10.1126. Rheumatology (Oxford). 2001. PMID: 11600742
[Team management of rheumatoid arthritis].
Le Loët X, Vittecoq O. Le Loët X, et al. Among authors: vittecoq o. Ann Med Interne (Paris). 2001 Dec;152(8):513-7. Ann Med Interne (Paris). 2001. PMID: 11937986 French.
Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.
Goëb V, Dieudé P, Daveau R, Thomas-L'otellier M, Jouen F, Hau F, Boumier P, Tron F, Gilbert D, Fardellone P, Cornélis F, Le Loët X, Vittecoq O. Goëb V, et al. Among authors: vittecoq o. Rheumatology (Oxford). 2008 Aug;47(8):1208-12. doi: 10.1093/rheumatology/ken192. Epub 2008 Jun 5. Rheumatology (Oxford). 2008. PMID: 18535030
Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patients.
de Bandt M, Fautrel B, Maillefert JF, Berthelot JM, Combe B, Flipo RM, Lioté F, Meyer O, Saraux A, Wendling D, Le Loët X, Guillemin F; STPR group of the French Society of Rheumatology. de Bandt M, et al. Arthritis Res Ther. 2009;11(5):R157. doi: 10.1186/ar2836. Epub 2009 Oct 23. Arthritis Res Ther. 2009. PMID: 19849865 Free PMC article.
205 results